Hello and Welcome to Patientsville.com, Your Source for all EZETIMIBE information. We are dedicated to provide You with EZETIMIBE safety information. Learn about EZETIMIBE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
EZETIMIBE Safety Reports
Total EZETIMIBE reports: 29.EZETIMIBE FDA safety alerts: No.
Reported hospitalizations: 12.
Take EZETIMIBE Side Effects Survey or Share Your EZETIMIBE Story. Read More Here.
Consumer or non-health professional from UNITED STATES reported EZETIMIBE problem on Jan 31, 2007. Male patient, 72 years of age, weighting 149.9 lb, was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: myalgia. EZETIMIBE dosage: unknown. Patient recovered.
EZETIMIBE problem was reported by a Physician from CANADA on Mar 29, 2007. Female patient, 73 years of age, was diagnosed with hyperlipidaemia, atrial fibrillation, arteriosclerosis coronary artery and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, fall, muscular weakness. EZETIMIBE dosage: unknown. During the same period patient was treated with WARFARIN, METOPROLOL, RAMIPRIL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on Apr 23, 2007. Male patient, 76 years of age, weighting 276.5 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis. EZETIMIBE dosage: 5 MG NIGHTLY PO. Patient recovered.
EZETIMIBE problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Male patient, 77 years of age, was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cardiac disorder, hepatic enzyme increased, hyperkalaemia, rhabdomyolysis, urine output decreased. EZETIMIBE dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on May 07, 2007. Male patient, 85 years of age, weighting 149.9 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: quadriparesis, renal failure, rhabdomyolysis. EZETIMIBE dosage: unknown. Patient was hospitalized. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on May 10, 2007. Female patient, 25 years of age, was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme abnormal. EZETIMIBE dosage: unknown. Patient recovered.
Physician from UNITED STATES reported EZETIMIBE problem on May 17, 2007. Female patient, 69 years of age, weighting 235.0 lb, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased. EZETIMIBE dosage: 10MG DAILY PO. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, 31 years of age, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, back pain, blood creatine phosphokinase increased, chromaturia, musculoskeletal pain, myalgia, pain in extremity. EZETIMIBE dosage: unknown. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported EZETIMIBE problem on June 04, 2007. Female patient, 60 years of age, weighting 145.5 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, muscular weakness. EZETIMIBE dosage: 10 MG DAILY PO. During the same period patient was treated with LIPITOR, GLUCOPHAGE, ASPIRIN. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. EZETIMIBE dosage: 10 MG DAILY PO. During the same period patient was treated with TERAZOSIN. Patient recovered.
Health Professional from GERMANY reported EZETIMIBE problem on July 14, 2006. Male patient, 75 years of age, was diagnosed with hypercholesterolaemia, coronary artery disease and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: hepatitis toxic, renal failure, rhabdomyolysis. EZETIMIBE dosage: unknown. During the same period patient was treated with CLOPIDOGREL BISULPHATE. Patient was hospitalized. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on July 27, 2006. Male patient, 85 years of age, weighting 151.5 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: musculoskeletal stiffness, paraesthesia. EZETIMIBE dosage: unknown. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on July 31, 2006. Male patient, weighting 120.0 lb, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, myalgia, rhabdomyolysis. EZETIMIBE dosage: 10 MG DAILY PO. During the same period patient was treated with SIMVASTATIN. Patient was hospitalized. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on Aug 02, 2006. Female patient, 73 years of age, weighting 224.9 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: pollakiuria, polyuria. EZETIMIBE dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported EZETIMIBE problem on Aug 02, 2006. Male patient, 69 years of age, weighting 189.8 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: abdominal pain. EZETIMIBE dosage: unknown. During the same period patient was treated with SIMVASTATIN. Patient recovered.
EZETIMIBE problem was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2006. Female patient, 66 years of age, weighting 176.4 lb, was diagnosed with blood cholesterol increased, angina pectoris, seasonal allergy and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased. EZETIMIBE dosage: unknown. During the same period patient was treated with ROSUVASTATIN CALCIUM, DILTIAZEM HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, ESTRADIOL, ISOSORBIDE MONONITRATE, NICORANDIL. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on Sept 21, 2006. Male patient, 70 years of age, weighting 205.9 lb, was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: myalgia. EZETIMIBE dosage: unknown. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on Sept 28, 2006. Male patient, 49 years of age, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: dysgeusia. EZETIMIBE dosage: 10 MG DAILY ORAL. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on Oct 04, 2006. Female patient, 82 years of age, weighting 195.0 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, transaminases increased. EZETIMIBE dosage: 10 MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.
EZETIMIBE problem was reported by a Health Professional from UNITED KINGDOM on Oct 04, 2006. Male patient, 91 years of age, was diagnosed with diabetes mellitus and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: fall, myopathy, troponin increased. EZETIMIBE dosage: 10 MG, ORAL. During the same period patient was treated with SIMVASTATIN, ALFACALCIDOL, AMLODIPINE, ASPIRIN, LISINOPRIL. Patient was hospitalized and became disabled. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on Oct 27, 2006. Male patient, 66 years of age, weighting 186.0 lb, was diagnosed with hyperlipidaemia, hypertriglyceridaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood amylase increased, electrocardiogram t wave peaked, haemodialysis, hyperkalaemia, lipase increased, renal failure acute, rhabdomyolysis. EZETIMIBE dosage: 10 MG/80 MG DAILY PO. During the same period patient was treated with GEMFIBROZIL. Patient was hospitalized. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on Nov 29, 2006. Male patient, 52 years of age, weighting 196.2 lb, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: gait disturbance, muscular weakness, myalgia. EZETIMIBE dosage: 10 MG/80 MG 1/2 TABLET QHS PO. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on Dec 01, 2006. Male patient, 56 years of age, weighting 190.9 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, liver function test abnormal, myalgia. EZETIMIBE dosage: unknown. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on Dec 08, 2006. Female patient, 60 years of age, weighting 210.1 lb, was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: myalgia, paralysis. EZETIMIBE dosage: 10 MG, QDAY, PO. Patient recovered.
Pharmacist from UNITED STATES reported EZETIMIBE problem on July 02, 2007. Male patient, 69 years of age, weighting 229.3 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: palpitations. EZETIMIBE dosage: 10/80MG EVERY DAY PO. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on July 03, 2007. Male patient, 69 years of age, weighting 229.3 lb, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: palpitations. EZETIMIBE dosage: 10/80MG EVERY DAY PO. Patient recovered.
Physician from UNITED STATES reported EZETIMIBE problem on Sept 13, 2007. Male patient, weighting 185.0 lb, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: arthralgia, myalgia, tendonitis. EZETIMIBE dosage: 10 MG DAILY PO. Patient recovered.
EZETIMIBE problem was reported by a Pharmacist from UNITED STATES on Sept 18, 2007. Male patient, 85 years of age, was diagnosed with hyperlipidaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: myalgia. EZETIMIBE dosage: 10MG EVERY DAY PO. Patient recovered.
Physician from LATVIA reported EZETIMIBE problem on Sept 26, 2007. Male patient, 69 years of age, weighting 189.6 lb, was diagnosed with hypercholesterolaemia and was treated with EZETIMIBE. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome. EZETIMIBE dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, AMIODARONE HYDROCHLORIDE, RAMIPRIL, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.